Certified by Founder Lodge
Soleus Capital Management, L.P.
United States - Greenwich, CT
INVESTOR
1 Disclosed Funding Rounds $41,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The Firm seeks to generate superior risk-adjusted returns through idiosyncratic, catalyst-driven investing with a focus on complex and niche opportunities in the Public and Private space.
| Company | Date | Round | Raised |
|---|---|---|---|
 Parse Biosciences |
February, 15 ,2022 | Series B | $41,500,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
 Pillar Biosciences Incorporated |
May, 28 ,2025 | Unknown | $34,500,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
